Viewing Study NCT00749294


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-01-01 @ 7:11 AM
Study NCT ID: NCT00749294
Status: COMPLETED
Last Update Posted: 2010-08-09
First Post: 2008-09-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anogenital Wart Burden and Cost of Illnesses
Sponsor: Mahidol University
Organization:

Study Overview

Official Title: Measurement of Anogenital Wart Burden, and Cost of Illnesses in Bangkok
Status: COMPLETED
Status Verified Date: 2010-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study will be a prospective study of patients presenting with anogenital warts. The objective are to assess proportion of anogenital warts to the total number of sexual transmitted infection patients, to quantify direct and indirect cost of illnesses and psychological burden associated with anogenital warts and to estimate government program expenditure for the prevention and control and treatment of the STI/anogenital HPV infection.
Detailed Description: An observational study, multiple visit, 2-center study will be conducted in Rajavithi General Hospital, and Bangrak Hospital. One hundred and fifty subjects will be enrolled from both hospitals. Anogenital wart patients presented in Rajavithi General Hospital and the STI clinic at Bangrak Hospital will be recruited prospectively. All patients will be treated according to standard medical guidelines or usual care of the institutes. After the baseline assessment, the patients will have follow up visits with their physicians and will also be interviewed at the clinical sites three time approximately at day 7 (-2+7 days), month 1 (+-7 days), and month 6 (+-7 days) until they are cure. At month 6 (+-14 days), telephone assessment for the capture of any signs of disease recurrence will be done. All patients will be followed for 6 months under the same schedule.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: